• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
 

1999 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Warning Letters for 1999

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
February 25, 1999 Continental Manufacturing Chemists Inc. [ARCHIVED] Kansas City District Office Quality System Regulations (QSR)/Sterile Surgical Procedural Kits N/A *
February 25, 1999 InterExpress Corporation [ARCHIVED] Florida District Office Seafood Processing Regulations/HACCP N/A *
February 25, 1999 Schering AG [ARCHIVED] Center for Drug Evaluation and Research Postmarketing Adverse Drug Experience N/A *
February 24, 1999 Limate Corporation [ARCHIVED] Center for Devices and Radiological Health Laser Products / Noncompliance N/A *
February 24, 1999 Berlex Laboratories Inc. [ARCHIVED] New Jersey District Office Postmarketing Adverse Drug Experience Reporting Requirements N/A *
February 24, 1999 Albany Edison Oxygen Company Inc. [ARCHIVED] New York District Office Medical Oxygen N/A *
February 24, 1999 Clarks Cove Fish Co. [ARCHIVED] New England District Office Seafood Processing Regulations/HACCP N/A *
February 24, 1999 Home Therapy Equipment Inc. [ARCHIVED] New York District Office Medical Oxygen N/A *
February 24, 1999 Berlex Laboratories Inc. New Jersey District Office Postmarketing Adverse Drug Experience Reporting Requirements N/A *
February 24, 1999 Clarks Cove Fish Co. New England District Office Seafood Processing Regulations/HACCP N/A *
February 24, 1999 Albany Edison Oxygen Company Inc. New York District Office Medical Oxygen N/A *
February 24, 1999 Limate Corporation Center for Devices and Radiological Health Laser Products / Noncompliance N/A *
February 24, 1999 Home Therapy Equipment Inc. New York District Office Medical Oxygen N/A *
February 23, 1999 Remel Inc. [ARCHIVED] Kansas City District Office In Vitro Diagnostic Products N/A *
February 23, 1999 Remel Inc. Kansas City District Office In Vitro Diagnostic Products N/A *
February 22, 1999 Compex S.A. [ARCHIVED] Center for Devices and Radiological Health Devices/Compex 2 N/A *
February 22, 1999 Alpha Therapeutic Corporation [ARCHIVED] Seattle District Office Blood Products / Standard Operating Procedures N/A *
February 22, 1999 CFG S.A. Microelectronic [ARCHIVED] Center for Devices and Radiological Health Devices/Compex 2 N/A *
February 22, 1999 Alpha Therapeutic Corporation Seattle District Office Blood Products / Standard Operating Procedures N/A *
February 22, 1999 Weiler Welding Inc. [ARCHIVED] Cincinnati District Office Medical Oxygen N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-